Eureka Bio

EurekaBio is a pioneering company in the field of cell and gene therapy, specializing in the development and industrialization of cutting-edge technology platforms and products. The company serves clients in the biotechnology and pharmaceutical sectors, focusing on automating the processing of blood samples to concentrate cells, remove platelets, and separate PBMCs (Peripheral Blood Mononuclear Cells). EurekaBio operates in the highly specialized market of cell and gene therapy, where precision and innovation are paramount. The business model revolves around providing advanced automated equipment and viral vector research and development services. Revenue is generated through the sale of these specialized equipment and services, catering to the needs of domestic and international clients who require high-quality, reliable solutions for their therapeutic research and development projects.

Keywords: cell therapy, gene therapy, automated equipment, blood sample processing, PBMC separation, viral vector R&D, biotechnology, pharmaceutical, innovation, industrialization.